Lipocine | 2.05 -7.20 -77.84% | ||
| LPCN | |||
| 高 2.11 | 开 2.01 | 量 740.22万股 | 总市值 1496.44万 |
| 低 1.81 | 换 101.40% | 额 1486.04万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Lipocine(LPCN)
15小时前
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-26-014959 Size: 4 KB 网页链接
Lipocine(LPCN)
昨天21:45
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-014834 Act: 34 Size: 267 KB 网页链接
Lipocine(LPCN)
昨天21:45
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-014835 Act: 34 Size: 8 MB 网页链接
Lipocine(LPCN)
03-10 18:15
$Lipocine(LPCN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-26-009428 Act: 34 Size: 311 KB 网页链接
Lipocine(LPCN)
03-10 18:05
$Lipocine(LPCN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-26-009411 Act: 34 Size: 8 MB 网页链接
Lipocine(LPCN)
03-05 05:15
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-008852 Act: 34 Size: 278 KB 网页链接
Lipocine(LPCN)
02-27 06:35
$Lipocine(LPCN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-26-008201 Act: 33 Size: 36 KB 网页链接
Lipocine(LPCN)
02-18 22:45
$Lipocine(LPCN)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001493152-26-007287 Act: 34 Size: 252 KB 网页链接
Lipocine(LPCN)
02-18 22:45
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-007288 Act: 34 Size: 25 MB 网页链接
Lipocine(LPCN)
02-18 00:55
$Lipocine(LPCN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0002050709-26-000004 Act: 34 Size: 80 KB 网页链接
Lipocine(LPCN)
01-20 22:35
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-002785 Act: 34 Size: 240 KB 网页链接
Lipocine(LPCN)
01-13 05:35
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-001864 Act: 34 Size: 21 MB 网页链接
Lipocine(LPCN)
01-12 22:35
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-001254 Act: 34 Size: 258 KB 网页链接
Lipocine(LPCN)
01-06 04:55
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-26-000361 Size: 5 KB 网页链接
Lipocine(LPCN)
2025-12-24 04:55
$Lipocine(LPCN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002050709-25-000012 Act: 34 Size: 80 KB 网页链接
Lipocine(LPCN)
2025-12-20 06:15
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-028593 Size: 5 KB 网页链接
Lipocine(LPCN)
2025-12-20 06:15
$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-028597 Size: 5 KB 网页链接
Lipocine(LPCN)
2025-12-16 22:55
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-027914 Act: 34 Size: 244 KB 网页链接
Lipocine(LPCN)
2025-12-16 06:36
$Lipocine(LPCN)$ 8-K Current report, item 5.02 Accession Number: 0001493152-25-027744 Act: 34 Size: 215 KB 网页链接
Lipocine(LPCN)
2025-12-12 06:05
$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-027273 Act: 34 Size: 2 MB 网页链接